acitretin has been researched along with Neuroblastoma in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Cai, A; Gao, K; Jiang, Y; Li, X; Lin, Z; Liu, N; Wang, J; Wu, Y | 1 |
Endres, K; Grimm, MO; Hartmann, T; Reinhardt, S; Shudo, K; Stahlmann, C; Tomita, T | 1 |
Endres, K; Fahrenholz, F; Hiemke, C; Holthoewer, D; Schmitt, U; Schuck, F | 1 |
3 other study(ies) available for acitretin and Neuroblastoma
Article | Year |
---|---|
In Vitro Effects of Acitretin on Human Neuronal SH-SY5Y Cells.
Topics: Acitretin; Cell Differentiation; Cell Line, Tumor; Humans; Nerve Tissue Proteins; Neuroblastoma; Neurons; Potassium Channels, Sodium-Activated | 2023 |
Rescue of Hypovitaminosis A Induces Non-Amyloidogenic Amyloid Precursor Protein (APP) Processing.
Topics: Acitretin; ADAM10 Protein; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Animals, Newborn; Cells, Cultured; Cerebral Cortex; Disease Models, Animal; Female; Gene Regulatory Networks; Humans; Keratolytic Agents; Mice; Neuroblastoma; Neurons; Peptide Fragments; Presenilin-2; Rats, Wistar; Tretinoin; Vitamin A Deficiency | 2016 |
Acitretin, an enhancer of alpha-secretase expression, crosses the blood-brain barrier and is not eliminated by P-glycoprotein.
Topics: Acitretin; ADAM Proteins; ADAM10 Protein; Amyloid Precursor Protein Secretases; Analysis of Variance; Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blood-Brain Barrier; Cell Line, Tumor; Chromatography, High Pressure Liquid; Gene Expression Regulation; Humans; Male; Membrane Proteins; Mice; Mice, Knockout; Neuroblastoma; Time Factors; Transfection | 2012 |